Seljeflot I - Search Results

1

Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease.

Seljeflot I, Tonstad S, Hjermann I, Arnesen H. Seljeflot I, et al. Atherosclerosis. 2002 May;162(1):179-85. doi: 10.1016/s0021-9150(01)00696-7. Atherosclerosis. 2002. PMID: 11947912 Clinical Trial.

2

Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.

Eritsland J, Seljeflot I, Arnesen H, Smith P, Westvik AB. Eritsland J, et al. Among authors: seljeflot i. Thromb Res. 1992 Apr 1;66(1):55-60. doi: 10.1016/0049-3848(92)90155-4. Thromb Res. 1992. PMID: 1412183 Clinical Trial.

3

Effects of gemfibrozil on lipids and haemostasis after myocardial infarction.

Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H. Andersen P, et al. Among authors: seljeflot i. Thromb Haemost. 1990 Apr 12;63(2):174-7. Thromb Haemost. 1990. PMID: 2194314 Clinical Trial.

4

Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile.

Eritsland J, Arnesen H, Smith P, Seljeflot I, Dahl K. Eritsland J, et al. Among authors: seljeflot i. J Oslo City Hosp. 1989 Aug-Sep;39(8-9):97-101. J Oslo City Hosp. 1989. PMID: 2809856 Clinical Trial.

5

Increased fibrinolytic activity after surgery induced by low dose heparin.

Arnesen H, Engebretsen LF, Ugland OM, Seljeflot I, Kierulf P. Arnesen H, et al. Among authors: seljeflot i. Thromb Res. 1987 Mar 1;45(5):553-9. doi: 10.1016/0049-3848(87)90318-5. Thromb Res. 1987. PMID: 3109060 Clinical Trial.

6

Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation.

Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M. Eritsland J, et al. Among authors: seljeflot i. Scand J Clin Lab Invest. 1995 Jul;55(4):295-300. doi: 10.3109/00365519509104966. Scand J Clin Lab Invest. 1995. PMID: 7569731 Clinical Trial.

7

Activated protein C resistance and graft occlusion after coronary artery bypass surgery.

Eritsland J, Gjønnes G, Sandset PM, Seljeflot I, Arnesen H. Eritsland J, et al. Among authors: seljeflot i. Thromb Res. 1995 Jul 15;79(2):223-6. doi: 10.1016/0049-3848(95)91526-q. Thromb Res. 1995. PMID: 7676409 Clinical Trial. No abstract available.

8

Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease.

Eritsland J, Arnesen H, Seljeflot I, Høstmark AT. Eritsland J, et al. Among authors: seljeflot i. Am J Clin Nutr. 1995 Apr;61(4):831-6. doi: 10.1093/ajcn/61.4.831. Am J Clin Nutr. 1995. PMID: 7702027 Clinical Trial.

9

Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease.

Eritsland J, Seljeflot I, Arnesen H, Westvik AB, Kierulf P. Eritsland J, et al. Among authors: seljeflot i. Thromb Res. 1995 Feb 15;77(4):337-46. doi: 10.1016/0049-3848(95)93837-p. Thromb Res. 1995. PMID: 7740525 Clinical Trial.

10

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Løvik A, Birkeland K. Andersen P, et al. Among authors: seljeflot i. Metabolism. 1995 May;44(5):611-6. doi: 10.1016/0026-0495(95)90118-3. Metabolism. 1995. PMID: 7752909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters